Agios has an innovative, dynamic culture, which supports our employees’ unwavering commitment to science and patients. World-class founding and management teams with the experience and a track record to provide the scientific insights required to develop groundbreaking medicines lead a group of exceptional employees.


Date Type Amount Investors Valuation
11/01/11 Series C 78M Celgene, Arch Venture Partners, Flagship Ventures, Third Rock Ventures Unknown